Parenteral Anticoagulant Therapy: Implications for Patient Management - Y8010

$12.95

About Course #Y8010

Start Date: September 10, 2019

Expiration Date: September 10, 2022

Anticoagulants are central to the management of cardiovascular and thrombotic conditions. Parenteral anticoagulants are particularly important in acute care situations given their fast onset of action. With the variety of oral anticoagulants now available, it is also important that pharmacists recognize the changing role of parenteral anticoagulants when the indications overlap with those of oral therapy. Furthermore, they must be able to safely transition patients from parenteral to oral anticoagulants.

This course is designed for pharmacists who are involved in decision making for parenteral anticoagulant selection or who provide care for patients who have already been prescribed a parenteral anticoagulant. The purpose of this course is to increase pharmacists' knowledge of parenteral anticoagulants so that they can identify patients in whom therapy is indicated, assist in selecting the most appropriate option, and monitor and counsel the patient.

Universal Activity Number (UAN) - 0607-0000-19-010-H01-P

Type of Activity - Knowledge

Topic Designator - 01 - Disease State Management/Drug Therapy

Course Objectives

  • Identify the current role of parenteral anticoagulants in the management of patients with venous thromboembolism (VTE) and for VTE prophylaxis, acute coronary syndromes (ACS), and heparininduced thrombocytopenia (HIT).
  • Compare and contrast parenteral anticoagulants, their respective pharmacologic class, and their approved indications.
  • Identify pertinent contraindications, side effects, drug interactions, monitoring parameters, and patient counseling points for parenteral anticoagulants.
  • Identify reversal agents for parenteral anticoagulants.

About the Author

Diana M. Sobieraj, PharmD, BCPS, earned her doctor of pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/The University of Connecticut (UCONN) School of Pharmacy. After her training, Dr. Sobieraj joined the faculty at UCONN School of Pharmacy, where she has worked for the past 8 years.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 23.76ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;